The current study aimed to evaluate the expression of the NLRP3 inflammasome and related ILs (1α, 1β, 18, 33 and 37) in the sera of PD participants who, after 6 months of lifestyle modification, either reverted to normal, remained PD or developed T2DM. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.